TG Therapeutics, Inc. (TGTX) Documents: SEC Filings, Investor Presentations & Press Releases

TG Therapeutics, Inc. (TGTX) documents, SEC filings and the IR site together: 70 documents, newest first; latest 2026-08-05. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site

Date	Type	Document
2026-08-05	10-Q	Form 10-Q for the quarter ended Jun 30
2026-08-03	8-K	Form 8-K, Item 2.02 results
2026-08-03	Transcript	Q2 FY26 earnings call transcript
2026-06-12	8-K	Form 8-K, Item 5.07
2026-06-03	8-K	Form 8-K, Item 8.01
2026-05-27	8-K	Form 8-K, Item 8.01
2026-05-06	8-K	Form 8-K, Item 2.02 results
2026-05-06	10-Q	Form 10-Q for the quarter ended Mar 31
2026-04-30	Proxy	Definitive proxy statement
2026-03-20	8-K	Form 8-K, Item 1.01
2026-02-27	10-K	Annual report on Form 10-K, FY25
2026-02-27	Transcript	Q4 FY25 earnings call transcript
2026-02-26	8-K	Form 8-K, Item 2.02 results
2026-01-13	8-K	Form 8-K, Item 7.01
2025-11-05	10-Q	Form 10-Q for the quarter ended Sep 30
2025-11-03	8-K	Form 8-K, Item 2.02 results
2025-08-08	10-Q	Form 10-Q for the quarter ended Jun 30
2025-08-04	8-K	Form 8-K, Item 2.02 results
2025-08-04	Transcript	Q2 FY25 earnings call transcript
2025-06-13	8-K	Form 8-K, Item 5.07
2025-05-09	10-Q	Form 10-Q for the quarter ended Mar 31
2025-05-05	8-K	Form 8-K, Item 2.02 results
2025-04-30	Proxy	Definitive proxy statement
2025-03-03	8-K	Form 8-K, Item 2.02 results
2025-03-03	10-K	Annual report on Form 10-K, FY24
2025-01-14	8-K	Form 8-K, Item 7.01
2024-11-07	10-Q	Form 10-Q for the quarter ended Sep 30
2024-11-04	8-K	Form 8-K, Item 2.02 results
2024-08-09	10-Q	Form 10-Q for the quarter ended Jun 30
2024-08-09	10-K	Annual report on Form 10-K/A, FY23
2024-08-06	8-K	Form 8-K, Item 2.02 results
2024-06-17	8-K	Form 8-K, Item 5.02
2024-05-06	10-Q	Form 10-Q for the quarter ended Mar 31
2024-05-01	8-K	Form 8-K, Item 2.02 results
2024-04-29	Proxy	Definitive proxy statement
2024-02-29	10-K	Annual report on Form 10-K, FY23
2024-02-28	8-K	Form 8-K, Item 2.02 results
2024-01-10	8-K	Form 8-K, Item 1.01
2023-11-06	10-Q	Form 10-Q for the quarter ended Sep 30
2023-11-01	8-K	Form 8-K, Item 2.02 results

TGTX overview · TGTX earnings · TGTX financials · TGTX KPIs · TGTX ownership · TGTX peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.